$PGNX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in PROGENICS PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in PROGENICS PHARMACEUTICALS INC. Get notifications about new insider transactions in PROGENICS PHARMACEUTICALS INC for free.

Page:   < prev 1 2 3 4 5 6 7 8 ... 13 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 09 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM5.332001,06641,800
Mar 09 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS6.332001,26643,37743.6 K to 43.4 K (-0.46 %)
Mar 09 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM5.332001,06643,57743.4 K to 43.6 K (+0.46 %)
Feb 08 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM5.337,59740,49242,000
Feb 08 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS6.337,59748,08943,37751 K to 43.4 K (-14.90 %)
Feb 08 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM5.337,59740,49250,97443.4 K to 51 K (+17.51 %)
Jan 20 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM5.334032,14849,597
Jan 20 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS6.334032,55143,37743.8 K to 43.4 K (-0.92 %)
Jan 20 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM5.334032,14843,78043.4 K to 43.8 K (+0.93 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA5.466,33734,6006,337
Jan 05 2011PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.832,71513,1080
Jan 05 2011PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF5.682,47314,04744,88647.4 K to 44.9 K (-5.22 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.832,71513,10847,35944.6 K to 47.4 K (+6.08 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA5.466,74536,8286,745
Jan 05 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM4.833,62517,5020
Jan 05 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Payment of ExerciseF5.683,30118,75043,37746.7 K to 43.4 K (-7.07 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM4.833,62517,50246,67843.1 K to 46.7 K (+8.42 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Option ExerciseD5.465,30828,9825,308
Jan 05 2011PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Option ExerciseM4.832,58212,4660
Jan 05 2011PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Payment of ExerciseF5.682,35113,35447,30449.7 K to 47.3 K (-4.73 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...BuyM4.832,58212,46649,65547.1 K to 49.7 K (+5.49 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseA5.4613,79375,31013,793
Jan 05 2011PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseM4.834,37721,1320
Jan 05 2011PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentPayment of ExerciseF5.684,01422,80029,75133.8 K to 29.8 K (-11.89 %)
Jan 05 2011PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentBuyM4.834,37721,13233,76529.4 K to 33.8 K (+14.89 %)
Dec 01 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.905,00024,500854,057849.1 K to 854.1 K (+0.59 %)
Nov 02 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.765,00023,800849,057844.1 K to 849.1 K (+0.59 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Option ExerciseA5.052,37311,9842,373
Oct 04 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Option ExerciseM4.326,91529,8590
Oct 04 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Payment of ExerciseF5.086,25431,77046,87153.1 K to 46.9 K (-11.77 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...BuyM4.326,91529,85953,12546.2 K to 53.1 K (+14.96 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA5.052,49512,6002,495
Oct 04 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.328,22935,5330
Oct 04 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF5.087,44237,80544,44251.9 K to 44.4 K (-14.34 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.328,22935,53351,88443.7 K to 51.9 K (+18.85 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA5.053,33216,8273,332
Oct 04 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM4.328,78637,9380
Oct 04 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Payment of ExerciseF5.087,94540,36142,85150.8 K to 42.9 K (-15.64 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM4.328,78637,93850,79642 K to 50.8 K (+20.91 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseA5.054,02220,3114,022
Oct 04 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseM4.3217,54575,7590
Oct 04 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentPayment of ExerciseF5.0815,97281,13829,18645.2 K to 29.2 K (-35.37 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentBuyM4.3217,54575,75945,15827.6 K to 45.2 K (+63.54 %)
Oct 04 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.995,00024,950844,057839.1 K to 844.1 K (+0.60 %)
Sep 02 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.105,00020,500839,057834.1 K to 839.1 K (+0.60 %)
Aug 02 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.755,00023,750834,057829.1 K to 834.1 K (+0.60 %)
Jul 19 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.9828139829,057829 K to 829.1 K (0.00 %)
Jul 19 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.994,97224,810829,029824.1 K to 829 K (+0.60 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseA5.35100,000535,000150,000
Jul 06 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseA5.3550,000267,50050,000
Jul 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseA5.35200,0001,070,000325,000
Jul 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseA5.35125,000668,750125,000
Jul 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseA5.483,70720,3143,707
Jul 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseM4.444,57520,3130
Jul 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentPayment of ExerciseF5.354,10821,97827,39531.5 K to 27.4 K (-13.04 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentBuyM4.444,57520,31331,50326.9 K to 31.5 K (+16.99 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...WILLIAMS NICOLEDirectorOption ExerciseA5.3510,00053,50010,000
Jul 06 2010PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorOption ExerciseA5.3510,00053,50010,000
Jul 06 2010PGNXPROGENICS PHARMACE ...GOFF STEPHEN PDirectorOption ExerciseA5.3510,00053,50010,000
Jul 06 2010PGNXPROGENICS PHARMACE ...DALTON MARK FDirectorOption ExerciseA5.3510,00053,50010,000
Jul 06 2010PGNXPROGENICS PHARMACE ...Crowley Peter JDirectorOption ExerciseA5.3540,000214,00040,000
Jul 06 2010PGNXPROGENICS PHARMACE ...BRINER KURT WDirectorOption ExerciseA5.3510,00053,50010,000
Jul 06 2010PGNXPROGENICS PHARMACE ...BAKER CHARLES ADirectorOption ExerciseA5.3510,00053,50010,000
Jul 06 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Option ExerciseA5.3530,000160,50030,000
Jul 06 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Option ExerciseA5.482,18711,9852,187
Jul 06 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Option ExerciseM4.442,54111,2820
Jul 06 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...GrantA0.0010,000045,99236 K to 46 K (+27.78 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...Payment of ExerciseF5.352,28212,20935,99238.3 K to 36 K (-5.96 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...Olson William CSR. VP, Research & ...BuyM4.442,54111,28238,27435.7 K to 38.3 K (+7.11 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA5.3530,000160,50030,000
Jul 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA5.482,16711,8752,167
Jul 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.442,67511,8770
Jul 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...GrantA0.0010,000043,43733.4 K to 43.4 K (+29.91 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF5.352,40212,85133,43735.8 K to 33.4 K (-6.70 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.442,67511,87735,83933.2 K to 35.8 K (+8.07 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA5.3530,000160,50030,000
Jul 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA5.483,07016,8243,070
Jul 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM4.443,59015,9400
Jul 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...GrantA0.0010,000041,79231.8 K to 41.8 K (+31.45 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Payment of ExerciseF5.353,22317,24331,79235 K to 31.8 K (-9.20 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM4.443,59015,94035,01531.4 K to 35 K (+11.42 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA5.3530,000160,50030,000
Jul 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA5.482,29912,5992,299
Jul 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseM4.442,67511,8770
Jul 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...GrantA0.0010,000047,13737.1 K to 47.1 K (+26.93 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Payment of ExerciseF5.352,40212,85137,13739.5 K to 37.1 K (-6.08 %)
Jul 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...BuyM4.442,67511,87739,53936.9 K to 39.5 K (+7.26 %)
Jun 24 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...SellS5.812,36413,72335,49437.9 K to 35.5 K (-6.24 %)
Jun 24 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS5.826,18035,96131,18637.4 K to 31.2 K (-16.54 %)
Jun 24 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...SellS5.742,40913,81836,62539 K to 36.6 K (-6.17 %)
Jun 24 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentSellS5.662,32813,18626,68929 K to 26.7 K (-8.02 %)
Jun 02 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.995,00024,950824,057819.1 K to 824.1 K (+0.61 %)
Jun 21 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...SellS6.254,00025,00032,92536.9 K to 32.9 K (-10.83 %)
May 21 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.934,49522,160819,057814.6 K to 819.1 K (+0.55 %)
May 21 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.895052,469814,562814.1 K to 814.6 K (+0.06 %)
Apr 07 2010PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...GrantA0.0044,7230849,665804.9 K to 849.7 K (+5.56 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseA5.333,81120,3133,811
Apr 05 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentOption ExerciseM4.564,30019,5910
Apr 05 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentPayment of ExerciseF5.363,91320,97429,01732.9 K to 29 K (-11.88 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentBuyM4.564,30019,59132,93028.6 K to 32.9 K (+15.02 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA5.332,99015,9372,990
Apr 05 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM4.563,51816,0280
Apr 05 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Payment of ExerciseF5.363,20117,15737,36640.6 K to 37.4 K (-7.89 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM4.563,51816,02840,56737 K to 40.6 K (+9.50 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseA5.332,11711,2842,117
Apr 05 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseM4.562,49011,3440
Apr 05 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Payment of ExerciseF5.362,26612,14637,85840.1 K to 37.9 K (-5.65 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...BuyM4.562,49011,34440,12437.6 K to 40.1 K (+6.62 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA5.332,22811,8752,228
Apr 05 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.562,62111,9410
Apr 05 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF5.362,38512,78436,92539.3 K to 36.9 K (-6.07 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.562,62111,94139,31036.7 K to 39.3 K (+7.14 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA5.332,22811,8752,228
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseM4.562,62111,9410
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Payment of ExerciseF5.362,38512,78439,03441.4 K to 39 K (-5.76 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...BuyM4.562,62111,94141,41938.8 K to 41.4 K (+6.76 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA5.332,22811,8752,228
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseM4.562,62111,9410
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Payment of ExerciseF5.362,38512,78439,03441.4 K to 39 K (-5.76 %)
Apr 05 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...BuyM4.562,62111,94141,41938.8 K to 41.4 K (+6.76 %)
Mar 18 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS5.377,05637,89136,84243.9 K to 36.8 K (-16.07 %)
Mar 18 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertPresidentSellS5.332,16511,53928,42330.6 K to 28.4 K (-7.08 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseA4.446,37028,2836,370
Jan 06 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseM3.782,98911,3070
Jan 06 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Payment of ExerciseF4.452,72012,10437,42740.1 K to 37.4 K (-6.78 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...BuyM3.782,98911,30740,14737.2 K to 40.1 K (+8.04 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA4.447,63033,8777,630
Jan 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM3.783,14711,9050
Jan 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF4.452,86412,74536,48239.3 K to 36.5 K (-7.28 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM3.783,14711,90539,34636.2 K to 39.3 K (+8.69 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA4.448,09435,9378,094
Jan 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM3.784,22315,9760
Jan 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Payment of ExerciseF4.453,84317,10143,89847.7 K to 43.9 K (-8.05 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM3.784,22315,97647,74143.5 K to 47.7 K (+9.70 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA4.447,63033,8777,630
Jan 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseM3.783,14711,9050
Jan 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Payment of ExerciseF4.452,86412,74538,59141.5 K to 38.6 K (-6.91 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...BuyM3.783,14711,90541,45538.3 K to 41.5 K (+8.21 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselOption ExerciseA4.4413,02157,81313,021
Jan 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselOption ExerciseM3.784,72017,8560
Jan 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselPayment of ExerciseF4.454,29519,11330,58834.9 K to 30.6 K (-12.31 %)
Jan 06 2010PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselBuyM3.784,72017,85634,88330.2 K to 34.9 K (+15.65 %)
Oct 19 2009PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyP4.8818,50090,243804,942786.4 K to 804.9 K (+2.35 %)
Oct 05 2009PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseA5.242,15311,2822,153
Oct 05 2009PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseM4.262,53310,7880
Oct 05 2009PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Payment of ExerciseF5.012,30511,54836,91039.2 K to 36.9 K (-5.88 %)
Oct 05 2009PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...BuyM4.262,53310,78839,21536.7 K to 39.2 K (+6.91 %)
Oct 05 2009PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA5.242,26611,8742,266
Oct 05 2009PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.262,66611,3540
Oct 05 2009PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF5.012,42612,15435,95138.4 K to 36 K (-6.32 %)

Page:   < prev 1 2 3 4 5 6 7 8 ... 13 next >

Contact us | Follow us on Twitter